SCHEMBL26050629

SCHEMBL26050629

CN(C)C1CC2(CCOCC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23055290 0.82 — —
SCHEMBL25788792 0.75 — —
SCHEMBL18737132 0.75 — —
SCHEMBL18792818 0.72 — —
SCHEMBL22520121 0.70 TSHR (0.30) —
SCHEMBL28704947 0.68 — —
SCHEMBL24071923 0.68 — —
SCHEMBL16384105 0.67 ESR1 (0.36) —
SCHEMBL12285060 0.67 — —
SCHEMBL18810536 0.67 CYP1A2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150203-A1 HDAC6 INHIBITORS AND USES THEREOF EIKONIZO THERAPEUTICS, INC. (US) 2023-08-10 — — WO disclosed
Send feedback